<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Complement Altern Med</journal-id><journal-id journal-id-type="iso-abbrev">BMC Complement Altern Med</journal-id><journal-title-group><journal-title>BMC Complementary and Alternative Medicine</journal-title></journal-title-group><issn pub-type="epub">1472-6882</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23043521</article-id><article-id pub-id-type="pmc">3519517</article-id><article-id pub-id-type="publisher-id">1472-6882-12-178</article-id><article-id pub-id-type="doi">10.1186/1472-6882-12-178</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>CCl<sub>4</sub>-induced hepatotoxicity: protective effect of rutin on p53, CYP2E1 and the antioxidative status in rat</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" equal-contrib="yes" id="A1"><name><surname>Khan</surname><given-names>Rahmat A</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>Rahmatgul_81@yahoo.com</email></contrib><contrib contrib-type="author" equal-contrib="yes" id="A2"><name><surname>Khan</surname><given-names>Muhammad R</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>mrkhaqau@yahoo.com</email></contrib><contrib contrib-type="author" equal-contrib="yes" id="A3"><name><surname>Sahreen</surname><given-names>Sumaira</given-names></name><xref ref-type="aff" rid="I2">2</xref><xref ref-type="aff" rid="I3">3</xref><email>sumairasahren@gmail.com</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Biotechnology, Faculty of Biological Sciences, University of Science and Technology Bannu, Khyber Pakhtunkhwa, Pakistan</aff><aff id="I2"><label>2</label>Department of Biochemistry, Faculty of Biological Sciences, Quaid-I-Azam University Islamabad, Islamabad, Pakistan</aff><aff id="I3"><label>3</label>Botanical Science Divisions, Pakistan Museum of Natural History, Islamabad, Pakistan</aff><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>8</day><month>10</month><year>2012</year></pub-date><volume>12</volume><fpage>178</fpage><lpage>178</lpage><history><date date-type="received"><day>17</day><month>8</month><year>2012</year></date><date date-type="accepted"><day>28</day><month>9</month><year>2012</year></date></history><permissions><copyright-statement>Copyright &#x000a9;2012 Khan et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2012</copyright-year><copyright-holder>Khan et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.biomedcentral.com/1472-6882/12/178"/><abstract><sec><title>Background</title><p>Rutin is a polyphenolic natural flavonoid which possesses antioxidant and anticancer activity. In the present study the hepatoprotective effect of rutin was evaluated against carbon tetrachloride (CCl<sub>4</sub>)-induced liver injuries in rats.</p></sec><sec><title>Methods and materials</title><p>24 Sprague&#x02013;Dawley male rats were equally divided into 4 groups for the assessment of hepatoprotective potential of rutin. Rats of group I (control) received only vehicles; 1 ml/kg bw of saline (0.85%) and olive oil (3 ml/kg) and had free access to food and water. Rats of group II, III and IV were treated with CCl<sub>4</sub> (30% in olive oil, 3 ml/kg bw) via the intraperitoneal route twice a week for four weeks. The rutin at the doses of 50 and 70 mg/kg were administered intragastrically after 48 h of CCl<sub>4</sub> treatment to group III and IV, respectively. Protective effect of rutin on serum enzyme level, lipid profile, activities of antioxidant enzymes and molecular markers were calculated in CCl<sub>4</sub>-induced hepatotoxicity in rat.</p></sec><sec><title>Results</title><p>Rutin showed significant protection with the depletion of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma glutamyl transpeptidase (&#x003b3;-GT) in serum as was raised by the induction of CCl<sub>4</sub>. Concentration of serum triglycerides, total cholesterol and low density lipoproteins was increased while high-density lipoprotein was decreased with rutin in a dose dependent manner. Activity level of endogenous liver antioxidant enzymes; catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GSHpx), glutathione-S-transferase (GST) and glutathione reductase (GSR) and glutathione (GSH) contents were increased while lipid peroxidation (TBARS) was decreased dose dependently with rutin. Moreover, increase in DNA fragmentation and oxo8dG damages while decrease in p53 and CYP 2E1 expression induced with CCl<sub>4</sub> was restored with the treatment of rutin.</p></sec><sec><title>Conclusion</title><p>From these results, it is suggested that rutin possesses hepatoprotective properties.</p></sec></abstract><kwd-group><kwd>Hepatotoxicity</kwd><kwd>Rutin</kwd><kwd>p53</kwd><kwd>CYP 2E1</kwd><kwd>Antioxidant enzymes</kwd></kwd-group></article-meta></front><body><sec><title>Background</title><p>Exposure to toxic chemicals, environmental pollutants and drugs can cause cellular injuries through metabolic activation of reactive oxygen species (ROS) [<xref ref-type="bibr" rid="B1">1</xref>]. Carbon tetrachloride (CCl<sub>4</sub>) has been used extensively to study hepatotoxicity in animal models by initiating lipid peroxidation, thereby causing injuries to kidney, heart, testis and brain [<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B4">4</xref>], in addition to liver pathogenesis [<xref ref-type="bibr" rid="B5">5</xref>]. Liver is particularly susceptible to oxidative stress due to the direct release of CCl<sub>4</sub> metabolites and cytokines, which propagate inflammatory response [<xref ref-type="bibr" rid="B6">6</xref>]. CCl<sub>4</sub> is one of the xenobiotics that has been reported to induce acute and chronic tissue injuries [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>] through bioactivation of the phase I cytochrome P450 system to form reactive metabolic trichloromethyl radicals (&#x000b7;CCl<sub>3</sub>) and peroxy trichloromethyl radicals (&#x000b7;OOCCl<sub>3</sub>). These free radicals can covalently bind to macromolecules such as proteins, lipids and nucleic acids. The double allylic hydrogen bonds of polyunsaturated fatty acid (PUFA) are susceptible to abstraction by free radicals; CCl<sub>4</sub> exposure induces an increase in lipoperoxide and free peroxide radical concentrations that are highly reactive and cause injury or necrosis [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>].</p><p>An increase in unsaturated fatty acid lipoperoxide and free peroxide radical concentrations [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>], can induce alterations in the cholesterol profile and decrease in hepatic antioxidant enzymes [<xref ref-type="bibr" rid="B13">13</xref>], in addition to induction of oxidative DNA damage including formation of DNA adducts, genetic mutations, strand breakage and chromosomal alterations [<xref ref-type="bibr" rid="B14">14</xref>]. These free radicals can cause depletion of CYP2E1 activity [<xref ref-type="bibr" rid="B15">15</xref>] and increase in oxo8dG concentration in tissues of experimental animals [<xref ref-type="bibr" rid="B16">16</xref>]. DNA fragmentation induces <italic>p53</italic> gene expression, blocks cells in the G phase of the cell cycle, and gives additional time for DNA repair, while severe DNA damage triggers apoptosis [<xref ref-type="bibr" rid="B17">17</xref>]. It has been reported that CCl<sub>4</sub> administration increases the silver-stained nucleolar organizer region, alters its size, morphology or spreading in the nucleus, which may be utilized as an indicator of genotoxicity, neoplasia and hyperplasia to complement other histological procedures [<xref ref-type="bibr" rid="B11">11</xref>].</p><p>Flavonoids are a large group of polyphenolic compounds that play an important role in detoxification of free radicals and are markedly found in fruits, vegetables and medicinal plants [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. Glycosidic flavonoids such as rutin are much more readily absorbed by humans than aglycones [<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>]. Rutin possesses antitumor [<xref ref-type="bibr" rid="B22">22</xref>], anti-inflammatory [<xref ref-type="bibr" rid="B23">23</xref>] and antimutagenic potential [<xref ref-type="bibr" rid="B24">24</xref>], besides myocardial protection [<xref ref-type="bibr" rid="B25">25</xref>] and immunomodulating activities [<xref ref-type="bibr" rid="B26">26</xref>]. Therefore, the present study was designed to investigate the hepatoprotective effects of rutin against CCl<sub>4</sub>-induced oxidative stress and its role in alleviation of lipid peroxidation and restoration of p53 and CYP2E1 activity.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Drugs and chemicals</title><p>Reduced glutathione (GSH), oxidized glutathione (GSSG), glutathione reductase, gamma-glutamyl p-nitroanilide, glycylglycine, bovine serum albumin (BSA), 1,2-dithio-bis nitro benzoic acid (DTNB), 1-chloro-2,4-dinitrobenzene (CDNB), reduced nicotinamide adenine dinucleotide phosphate (NADPH), rutin, CCl<sub>4</sub>, flavine adenine dinucleotide (FAD), glucose-6-phosphate, Tween-20, 2,6-dichlorophenolindophenol, thiobarbituric acid (TBA), picric acid, sodium tungstate, sodium hydroxide, trichloroacetic acid (TCA) and perchloric acid (PCA) were purchased from Sigma Chemicals Co. USA.</p></sec><sec><title>Animals and treatment</title><p>Six week old, 24 Sprague&#x02013;Dawley male rats (200&#x02013;210 g) were provided by National Institute of Health Islamabad and were kept in ordinary cages at room temperature of 25&#x000b1;3&#x000b0;C with a 12 h dark/light cycles. They have free access to standard laboratory feed and water, according to the study protocol approved by Ethical Committee of Quaid-i-Azam University Islamabad for animal care and experimentation. To study the hepatoprotective effects of rutin, rats were equally divided into four groups (six rats). Animals of group I were treated with 1 ml/kg bw of saline (0.85%) intragastrically and olive oil (3 ml/kg bw) intraperitoneally twice a week for four weeks. Rats of group II, III and IV were treated with CCl<sub>4</sub> (30% in olive oil) at a dose of 3 ml/kg bw intraperitoneally twice a week for four weeks. Animals of group II received only CCl<sub>4</sub> treatment. However, animals of group III and IV received rutin at a dose of 50 and 70 mg/kg bw intragastrically, respectively, in addition to CCl<sub>4</sub> treatment, twice a week for four weeks.</p><p>After 24 h of the last treatment, all the animals were weighted, sacrificed, collected the blood while liver was removed, weighted and perfuse in ice-cold saline solution. Liver samples were treated with liquid nitrogen and stored at &#x02212;70 &#x000b0;C for further studies.</p></sec><sec><title>Assessment of hepatotoxicity</title><p>Liver marker enzymes (alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma glutamyl transpeptidase (&#x003b3;-GT), lipid profile [total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL) and triglyceride] were estimated by using standard AMP diagnostic kits (Stattogger Strasse 31b 8045 Graz, Austria). CYP 2E1 (cat no: E90988Ra, Uscn Life Science Inc.), oxo8dG and p53 (PUMA ELISA Kit cat no: E91909Ra) concentration was determined with ELISA kit.</p></sec><sec><title>Assessment of oxidative stress</title><p>For determination of oxidative stress liver tissue was homogenized in 10 volumes of 100 mmol KH<sub>2</sub>PO<sub>4</sub> buffer containing 1 mmol EDTA (pH 7.4) and centrifuged at 12,000 &#x000d7; g for 30 min at 4 &#x000b0;C. The supernatant was collected and used for the determination of protein and enzymatic studies as described below. Protein concentration was determined by using crystalline BSA as standard. CAT and SOD activities are determined with protocol of [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>] while phase II metabolizing enzyme, including glutathione-S-transferase (GST), glutathione reductase (GSR), glutathione peroxidase (GSH-Px), reduced glutathione (GSH) [<xref ref-type="bibr" rid="B29">29</xref>-<xref ref-type="bibr" rid="B32">32</xref>] and thiobarbituric acid reactive substances (TBARS) contents, respectively [<xref ref-type="bibr" rid="B33">33</xref>].</p></sec><sec><title>DNA damages</title><p>Hepatic DNA damages (fragmentation % by DPA assay), DNA ladder assay [<xref ref-type="bibr" rid="B34">34</xref>] and number of NORs per cell [<xref ref-type="bibr" rid="B35">35</xref>] were determined.</p></sec><sec><title>Statistical analysis</title><p>To determine the treatment effects, one-way analysis of variance was carried by computer software SPSS 13.0. Level of significance among the various treatments was determined by LSD at 0.05% and 0.01% level of probability.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Body weight, liver weight</title><p>Treatment of CCl<sub>4</sub> caused significant reduction <italic>(P&#x0003c;</italic>0.01<italic>)</italic> in body weight while increased the absolute liver and relative liver weight comparatively to control group was significantly <italic>(P&#x0003c;</italic>0.01<italic>)</italic> restored with 50 mg/kg bw and 70 mg/kg bw treatment of rutin (Table <xref ref-type="table" rid="T1">1</xref>).</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Effect of Rutin on absolute liver weight, relative liver weight, and % increase in body weight</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="char"/><col align="char"/><col align="char"/></colgroup><thead valign="top"><tr><th align="left"><bold>Treatment</bold></th><th align="center"><bold>% increase in body weight</bold></th><th align="center"><bold>Absolute liver weight (g)</bold></th><th align="center"><bold>Relative liver weight (% to body weight)</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom">Control<hr/></td><td align="char" valign="bottom" char=".">35.00&#x000b1;0.87++<hr/></td><td align="char" valign="bottom" char=".">7.00&#x000b1;0.23++<hr/></td><td align="char" valign="bottom" char=".">0.072&#x000b1;0.02++<hr/></td></tr><tr><td align="left" valign="bottom">3 ml/kg CCl<sub>4</sub><hr/></td><td align="char" valign="bottom" char=".">24.52&#x000b1;0.92**<hr/></td><td align="char" valign="bottom" char=".">8.62&#x000b1;.89**<hr/></td><td align="char" valign="bottom" char=".">0.086&#x000b1;0.01**<hr/></td></tr><tr><td align="left" valign="bottom">50 mg/kg Rutin+CCl<sub>4</sub><hr/></td><td align="char" valign="bottom" char=".">30.85&#x000b1;0.96++<hr/></td><td align="char" valign="bottom" char=".">7.21&#x000b1;0.15++<hr/></td><td align="char" valign="bottom" char=".">0.072&#x000b1;0.01++<hr/></td></tr><tr><td align="left">70 mg/kg Rutin+CCl<sub>4</sub></td><td align="char" char=".">34.09&#x000b1;0.85++</td><td align="char" char=".">7.19&#x000b1;0.17++</td><td align="char" char=".">0.079&#x000b1;0.03++</td></tr></tbody></table><table-wrap-foot><p>Mean &#x000b1;SE (n=6 number).</p><p>** indicate significance from the control group at <italic>P&#x0003c;</italic>0.01 probability level.</p><p>++ indicate significance from the CCl<sub>4</sub> group at <italic>P&#x0003c;</italic>0.01 probability level.</p></table-wrap-foot></table-wrap></sec><sec><title>Lipids profile</title><p>Administration of CCl<sub>4</sub> increased triglycerides, total cholesterol, LDL while decreased the HDL as shown in Table <xref ref-type="table" rid="T2">2</xref>. Concentration of HDL was significantly (P&#x0003c;0.01) increased by rutin whereas concentration of triglycerides, total cholesterol and LDL was appreciably <italic>(P&#x0003c;</italic>0.01<italic>)</italic> augmented to compensate the CCl<sub>4</sub>-induced toxicity.</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Effect of Rutin on Lipids profile</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="char"/><col align="char"/><col align="char"/><col align="char"/></colgroup><thead valign="top"><tr><th align="left"><bold>Treatment</bold></th><th align="center"><bold>Triglycerides (mg/dl)</bold></th><th align="center"><bold>Total cholesterol (mg/dl)</bold></th><th align="center"><bold>High density lipoprotein (mg/dl)</bold></th><th align="center"><bold>Low density lipoprotein(mg/dl)</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom">Control<hr/></td><td align="char" valign="bottom" char=".">7.82&#x000b1;0.45++<hr/></td><td align="char" valign="bottom" char=".">6.13&#x000b1;0.25++<hr/></td><td align="char" valign="bottom" char=".">3.62&#x000b1;0.21++<hr/></td><td align="char" valign="bottom" char=".">2.48&#x000b1;0.32++<hr/></td></tr><tr><td align="left" valign="bottom">3 ml/kg CCl<sub>4</sub><hr/></td><td align="char" valign="bottom" char=".">11.13&#x000b1;0.58**<hr/></td><td align="char" valign="bottom" char=".">11.22&#x000b1;0.23**<hr/></td><td align="char" valign="bottom" char=".">2.83&#x000b1;0.18**<hr/></td><td align="char" valign="bottom" char=".">8.42&#x000b1;0.17**<hr/></td></tr><tr><td align="left" valign="bottom">50 mg/kg Rutin+CCl<sub>4</sub><hr/></td><td align="char" valign="bottom" char=".">8.51&#x000b1;0.44++<hr/></td><td align="char" valign="bottom" char=".">5.72&#x000b1;0.20++<hr/></td><td align="char" valign="bottom" char=".">3.24&#x000b1;0.23++<hr/></td><td align="char" valign="bottom" char=".">2.52&#x000b1;0.28++<hr/></td></tr><tr><td align="left">70 mg/kg Rutin+CCl<sub>4</sub></td><td align="char" char=".">7.93&#x000b1;0.90++</td><td align="char" char=".">6.94&#x000b1;0.52++</td><td align="char" char=".">3.82&#x000b1;0.28++</td><td align="char" char=".">2.68&#x000b1;0.29++</td></tr></tbody></table><table-wrap-foot><p>Mean &#x000b1;SE (n=6 number).</p><p>** indicate significance from the control group at <italic>P&#x0003c;</italic>0.01 probability level.</p><p>++ indicate significance from the CCl<sub>4</sub> group at <italic>P&#x0003c;</italic>0.01 probability level.</p></table-wrap-foot></table-wrap></sec><sec><title>Genotoxicity studies</title><p>Exposure of CCl<sub>4</sub> elicited the hepatic DNA damages (% fragmentation) and number of AgNORs/cell. Percent serum level of oxo8dG was increased whereas the % activity level of p53 and CYP 2E1 was decreased in hepatic samples of rat. Treatment of rats with 50 mg/kg bw and 70 mg/kg bw of rutin restored the level of these markers (Table <xref ref-type="table" rid="T3">3</xref>). DNA ladder assay showed conformity to the DNA fragmentation assay (Figure <xref ref-type="fig" rid="F1">1</xref>).</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Effect of Rutin on Genotoxicity studies</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="char"/><col align="char"/><col align="char"/><col align="char"/><col align="char"/></colgroup><thead valign="top"><tr><th align="left"><bold>Treatment</bold></th><th align="center"><bold>AgNORS (NORs/cell)</bold></th><th align="center"><bold>%DNA fragmentation</bold></th><th align="center"><bold>% oxo8dG</bold></th><th align="center"><bold>% p53</bold></th><th align="center"><bold>% CYP 2E1</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom">Control<hr/></td><td align="char" valign="bottom" char="&#x000b1;">2.02&#x000b1;0.33++<hr/></td><td align="char" valign="bottom" char="&#x000b1;">5.33&#x000b1;1.46++<hr/></td><td align="char" valign="bottom" char="&#x000b1;">4.10&#x000b1;0.53++<hr/></td><td align="char" valign="bottom" char="&#x000b1;">7.13&#x000b1;0.63++<hr/></td><td align="char" valign="bottom" char="&#x000b1;">15.23&#x000b1;1.09++<hr/></td></tr><tr><td align="left" valign="bottom">3 ml/kg CCl<sub>4</sub><hr/></td><td align="char" valign="bottom" char="&#x000b1;">6.42&#x000b1;0.29**<hr/></td><td align="char" valign="bottom" char="&#x000b1;">22.50&#x000b1;3.68**<hr/></td><td align="char" valign="bottom" char="&#x000b1;">11.20&#x000b1;0.27**<hr/></td><td align="char" valign="bottom" char="&#x000b1;">3.41&#x000b1;0.49**<hr/></td><td align="char" valign="bottom" char="&#x000b1;">8.10&#x000b1;0.78**<hr/></td></tr><tr><td align="left" valign="bottom">50 mg/kg Rutin+CCl<sub>4</sub><hr/></td><td align="char" valign="bottom" char="&#x000b1;">3.32&#x000b1;0.76++<hr/></td><td align="char" valign="bottom" char="&#x000b1;">7.61&#x000b1;1.04++<hr/></td><td align="char" valign="bottom" char="&#x000b1;">6.13&#x000b1;0.26++<hr/></td><td align="char" valign="bottom" char="&#x000b1;">5.15&#x000b1;0.46++<hr/></td><td align="char" valign="bottom" char="&#x000b1;">12.16&#x000b1;1.04++<hr/></td></tr><tr><td align="left">70 mg/kg Rutin+CCl<sub>4</sub></td><td align="char" char="&#x000b1;">3.11&#x000b1;0.35++</td><td align="char" char="&#x000b1;">5.00&#x000b1;1.83++</td><td align="char" char="&#x000b1;">5.20&#x000b1;0.85++</td><td align="char" char="&#x000b1;">7.10&#x000b1;0.55++</td><td align="char" char="&#x000b1;">14.22&#x000b1;1.33++</td></tr></tbody></table><table-wrap-foot><p>Mean &#x000b1;SE (n=6 number).</p><p>** indicate significance from the control group at <italic>P&#x0003c;</italic>0.01 probability level.</p><p>++ indicate significance from the CCl<sub>4</sub> group at <italic>P&#x0003c;</italic>0.01 probability level.</p></table-wrap-foot></table-wrap><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Protective effects of rutin on DNA; Lane 1&#x02013;4 (non treated control), 5&#x02013;8 (CCl</bold><sub><bold>4</bold></sub><bold>treated rats), 9,10 (CCl</bold><sub><bold>4</bold></sub><bold>+50 mg/kg b. w. rutin), 11,12 (CCl</bold><sub><bold>4</bold></sub><bold>+70 mg/kg b.w. rutin).</bold></p></caption><graphic xlink:href="1472-6882-12-178-1"/></fig></sec><sec><title>Indices of hepatotoxicity</title><p>Administration of CCl<sub>4</sub> markedly increased (P&#x0003c;0.01) the activity of liver serum marker enzymes such as AST, ALT, ALP and &#x003b3;-GT as compared with the control group. Elevations in the secretion of these enzymes were significantly decreased (P&#x0003c;0.01) by 50 mg/kg bw and 70 mg/kg bw of rutin as compared to the CCl<sub>4</sub> group are shown in Table <xref ref-type="table" rid="T4">4</xref>.</p><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Effect of Rutin on Indices of hepatotoxicity</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="char"/><col align="char"/><col align="char"/><col align="char"/></colgroup><thead valign="top"><tr><th align="left"><bold>Treatment</bold></th><th align="center"><bold>ALT (U/L)</bold></th><th align="center"><bold>AST (U/L)</bold></th><th align="center"><bold>ALP (U/L)</bold></th><th align="center"><bold>&#x003b3;-GT (nM/min /mg protein)</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom">Control<hr/></td><td align="char" valign="bottom" char="&#x000b1;">52.11&#x000b1;2.12++<hr/></td><td align="char" valign="bottom" char="&#x000b1;">76.32&#x000b1;2.74++<hr/></td><td align="char" valign="bottom" char="&#x000b1;">198.10&#x000b1;3.93++<hr/></td><td align="char" valign="bottom" char="&#x000b1;">105.25&#x000b1;2.22++<hr/></td></tr><tr><td align="left" valign="bottom">3 ml/kg CCl<sub>4</sub><hr/></td><td align="char" valign="bottom" char="&#x000b1;">111.01&#x000b1;3.42**<hr/></td><td align="char" valign="bottom" char="&#x000b1;">234.10&#x000b1;4.27**<hr/></td><td align="char" valign="bottom" char="&#x000b1;">470.13&#x000b1;6.49**<hr/></td><td align="char" valign="bottom" char="&#x000b1;">154.03&#x000b1;3.02**<hr/></td></tr><tr><td align="left" valign="bottom">50 mg/kg Rutin+CCl<sub>4</sub><hr/></td><td align="char" valign="bottom" char="&#x000b1;">58.01&#x000b1;2.68++<hr/></td><td align="char" valign="bottom" char="&#x000b1;">102.13&#x000b1;4.99++<hr/></td><td align="char" valign="bottom" char="&#x000b1;">227.05&#x000b1;3.89++<hr/></td><td align="char" valign="bottom" char="&#x000b1;">111.03&#x000b1;3.04++<hr/></td></tr><tr><td align="left">70 mg/kg Rutin+CCl<sub>4</sub></td><td align="char" char="&#x000b1;">56.12&#x000b1;2.05++</td><td align="char" char="&#x000b1;">98.61&#x000b1;2.75++</td><td align="char" char="&#x000b1;">209.06&#x000b1;3.68++</td><td align="char" char="&#x000b1;">107.23&#x000b1;2.01++</td></tr></tbody></table><table-wrap-foot><p>Mean &#x000b1;SE (n=6 number).</p><p>** indicate significance from the control group at <italic>P&#x0003c;</italic>0.01 probability level.</p><p>++ indicate significance from the CCl<sub>4</sub> group at <italic>P&#x0003c;</italic>0.01 probability level.</p></table-wrap-foot></table-wrap></sec><sec><title>Assessment of oxidative stress</title><p>CCl<sub>4</sub> treatment in rats significantly decreased <italic>(P&#x0003c;</italic>0.01<italic>)</italic> the activity of CAT, SOD, GST, GSH-Px, GSR, GSH while increased TBARS contents in liver samples. The increase of lipid peroxidation caused; reduction in the activities of antioxidant enzymes and glutathione (GSH) contents were markedly attenuated <italic>(P&#x0003c;</italic>0.01<italic>)</italic> by administration of 50 mg/kg bw and 70 mg/kg bw of rutin in intoxicated rats (Table <xref ref-type="table" rid="T5">5</xref>).</p><table-wrap position="float" id="T5"><label>Table 5</label><caption><p>Effect of Rutin on assessment of oxidative stress</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th align="left"><bold>Treatment</bold></th><th align="left"><bold>CAT (U/min)</bold></th><th align="left"><bold>SOD (U/mg protein)</bold></th><th align="left"><bold>GST nM /min/mg protein</bold></th><th align="left"><bold>GSH-Px nM/min/mg protein</bold></th><th align="left"><bold>GSR nM /min/mg protein</bold></th><th align="left"><bold>GSH (&#x003bc;M /g tissue)</bold></th><th align="left"><bold>TBARS (nM /min/mg protein)</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom">Control<hr/></td><td align="left" valign="bottom">4.81&#x000b1;0.10++<hr/></td><td align="left" valign="bottom">22.71&#x000b1;1.18++<hr/></td><td align="left" valign="bottom">192.12&#x000b1;2.49++<hr/></td><td align="left" valign="bottom">84.12&#x000b1;5.19++<hr/></td><td align="left" valign="bottom">127.23&#x000b1;10.52++<hr/></td><td align="left" valign="bottom">1.23&#x000b1;0.02++<hr/></td><td align="left" valign="bottom">28.33&#x000b1;1.12++<hr/></td></tr><tr><td align="left" valign="bottom">3 ml/kg CCl<sub>4</sub><hr/></td><td align="left" valign="bottom">2.91&#x000b1;0.06**<hr/></td><td align="left" valign="bottom">11.91&#x000b1;0.38**<hr/></td><td align="left" valign="bottom">104.23&#x000b1;2.14**<hr/></td><td align="left" valign="bottom">46.12&#x000b1;3.62**<hr/></td><td align="left" valign="bottom">62.33&#x000b1;9.28**<hr/></td><td align="left" valign="bottom">0.60&#x000b1;.01**<hr/></td><td align="left" valign="bottom">52.17&#x000b1;2.61**<hr/></td></tr><tr><td align="left" valign="bottom">50 mg/kg Rutin+CCl<sub>4</sub><hr/></td><td align="left" valign="bottom">4.60&#x000b1;0.16++<hr/></td><td align="left" valign="bottom">19.52&#x000b1;0.47++<hr/></td><td align="left" valign="bottom">175.21&#x000b1;2.19++<hr/></td><td align="left" valign="bottom">70.23&#x000b1;4.31++<hr/></td><td align="left" valign="bottom">101.13&#x000b1;9.14++<hr/></td><td align="left" valign="bottom">1.17&#x000b1;0.04++<hr/></td><td align="left" valign="bottom">31.17&#x000b1;1.74++<hr/></td></tr><tr><td align="left">70 mg/kg Rutin+CCl<sub>4</sub></td><td align="left">5.03&#x000b1;0.09++</td><td align="left">21.41&#x000b1;0.62++</td><td align="left">183.32&#x000b1;3.09++</td><td align="left">80.12&#x000b1;6.82++</td><td align="left">121.12&#x000b1;12.24++</td><td align="left">1.18&#x000b1;0.01++</td><td align="left">27.14&#x000b1;1.22++</td></tr></tbody></table><table-wrap-foot><p>Mean &#x000b1;SE (n=6 number).</p><p>** indicate significance from the control group at <italic>P&#x0003c;</italic>0.01 probability level.</p><p>++ indicate significance from the CCl<sub>4</sub> group at <italic>P&#x0003c;</italic>0.01 probability level.</p></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>The fields of dietary modification and chemoprevention show considerable effective approaches against oxidative stress and are the focus of research these days [<xref ref-type="bibr" rid="B36">36</xref>]. Various studies have shown that several mutagens and carcinogens cause generation of oxygen-free radicals, which play a major role in the emergence of cancer and other health disturbances [<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B38">38</xref>]. The present study revealed that CCl<sub>4</sub>-induction in rats remarkably increased the level of ALT, AST, ALP and &#x003b3;-GT. CCl<sub>4</sub> causes acute hepatocyte injuries, altered membrane integrity and as a result enzymes in hepatocytes leak out [<xref ref-type="bibr" rid="B39">39</xref>]. However, after treatment with rutin, the pathological increases in ALT, AST, ALP and &#x003b3;-GT were significantly restored. These results indicate that rutin has the ability to protect against CCl<sub>4</sub>-induced hepatocyte injury, which is in agreement with a previous study [<xref ref-type="bibr" rid="B40">40</xref>] that reported the protective consequence of polyphenolic compounds against CCl<sub>4</sub>-induced liver cirrhosis. Importantly, the increased serum concentrations of triglycerides, total cholesterol and LDL, and the decreased level of HDL, were restored to normal values with rutin co-treatment<italic>.</italic> This may be explained on the basis that rutin has a strong ability to chelate multivalent metal ions, especially zinc, calcium and iron. Indeed, its ability to chelate minerals has been reported to have some protective effects, such as decreasing iron mediated free radical formation and lowering serum cholesterol, triglycerides and lipid peroxides in experimental animals [<xref ref-type="bibr" rid="B41">41</xref>]<italic>.</italic> Similar findings were reported in another study [<xref ref-type="bibr" rid="B42">42</xref>] that investigated the hepatoprotective effects of plant bioactive compounds against CCl<sub>4</sub>-induced hepatic injury in rats.</p><p>ROS formed during the biotransformation process of CCl<sub>4</sub> are more reactive and toxic than the parental compound. Biotransformation of CCl<sub>4</sub> occurs in the endoplasmic reticulum and the isoenzyme implicated in this process is CYP2E1 [<xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B44">44</xref>]. Our results showed that the active free radical/intermediate of CCl<sub>4</sub> caused a reduction in CYP2E1, which was markedly restored by rutin treatment. Our results showed conformity with previous investigations, which demonstrated that the polyphenolic natural product is responsible for its protective, effects [<xref ref-type="bibr" rid="B45">45</xref>,<xref ref-type="bibr" rid="B46">46</xref>].</p><p>Results of the present study revealed that exposure of rats to CCl<sub>4</sub> resulted in depletion of antioxidant activities. In consonance with our results, Szymonik-Lesiuk <italic>et al.</italic>[<xref ref-type="bibr" rid="B1">1</xref>] reported that CCl<sub>4</sub> intoxication leads to changes in antioxidant enzymes and reactive intermediates involved in the bioactivation of CCl<sub>4</sub> that may truss to those enzymes to prevent their inactivation. Furthermore, our results correspond with [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>], and are in agreement with an investigation following CCl<sub>4</sub> intoxication [<xref ref-type="bibr" rid="B47">47</xref>].</p><p>Glutathione provides a first line of defense and scavenges free radical oxygen species (ROS). The decreased concentration of GSH in liver may be due to NADPH reduction or GSH utilization in the exclusion of peroxides [<xref ref-type="bibr" rid="B48">48</xref>]. GSH-dependent enzymes offer a second line of protection as they primarily detoxify noxious byproducts generated by ROS and help to avert dissemination of free radicals [<xref ref-type="bibr" rid="B49">49</xref>]. GSH-Px detoxifies peroxides by reacting with GSH and converting it into GSSG, which is reduced to GSH by GSR [<xref ref-type="bibr" rid="B50">50</xref>]. Our study revealed that CCl<sub>4</sub> treatment in rats markedly changed the activity of antioxidant enzymes, which was reverted by the co-administration of rutin. Thiobarbituric acid reactive substances (TBARS), the final metabolites of peroxidized polyunsaturated fatty acids, are considered as a late biomarker of oxidative stress [<xref ref-type="bibr" rid="B51">51</xref>]. In our experiments, major decrease in lipid peroxidation and consequent reduction in TBARS were obtained by treatment with rutin. The increment in lipid peroxidation, as assessed by the elevated levels of TBARS following CCl<sub>4</sub> administration, has been well documented [<xref ref-type="bibr" rid="B12">12</xref>]. Data of the present study indicated that lipid peroxidation induced by oxidative stress caused DNA damage. TBARS react with the DNA strand to form the M<sub>1</sub>G adduct, the mutagenic pirimedopurinone adduct of deoxyguanosine [<xref ref-type="bibr" rid="B52">52</xref>]. Administration of rutin markedly reduced the DNA damage, which is in close agreement with a previous study [<xref ref-type="bibr" rid="B11">11</xref>]. This level of DNA damage decreases the expression of p53 and blocks cells in the G phase of the cell cycle, which gives the cells additional time to repair the DNA damage. However, severe DNA damage may elicit apoptosis [<xref ref-type="bibr" rid="B53">53</xref>]. The data revealed that CCl<sub>4</sub>-induction caused marked reduction in p53. This result may be explained on the basis that CCl<sub>4</sub> acts as a tumor promoter through increasing the intracellular concentration of ROS necrosis/regeneration and cell proliferation and/or may be due to mutation of p53. Our results regarding p53 are in agreement with previous studies [<xref ref-type="bibr" rid="B54">54</xref>,<xref ref-type="bibr" rid="B55">55</xref>].</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>These results demonstrate that administration of rutin may be useful in the treatment and prevention of hepatic stress.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors&#x02019; contributions</title><p><bold>RAK</bold> made a significant contribution to conception and design of the study, acquisition and analyses of data and drafting of the manuscript. <bold>MRK</bold> and <bold>SS</bold> made contribution in sample collection and design. All the authors read the revised manuscript and approved.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1472-6882/12/178/prepub">http://www.biomedcentral.com/1472-6882/12/178/prepub</ext-link></p></sec></body><back><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Szymonik-Lesiuk</surname><given-names>SM</given-names></name><name><surname>Czechowska</surname><given-names>M</given-names></name><name><surname>Stryjecka-Zimmer</surname><given-names>M</given-names></name><name><surname>Somka</surname><given-names>A</given-names></name><name><surname>Madro</surname><given-names>K</given-names></name><name><surname>Celiski</surname><given-names>M</given-names></name><name><surname>Wielosz</surname><given-names>M</given-names></name><article-title>Catalase, superoxide dismutase, and glutathion peroxidase activities in various rat tissues after carbon tetrachloride intoxication</article-title><source>J</source><year>2003</year><volume>10</volume><fpage>309</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1007/s00534-002-0824-5</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Tirkey</surname><given-names>NG</given-names></name><name><surname>Kaur</surname><given-names>G</given-names></name><name><surname>Vij</surname><given-names>K</given-names></name><name><surname>Chopra</surname><given-names>K</given-names></name><article-title>Hesperidin, a citrus bioflavonoid, decreases the oxidative stress produced by carbon tetrachloride in rat liver and kidney</article-title><source>BMC Pharmacol</source><year>2005</year><volume>5</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1186/1471-2210-5-15</pub-id><pub-id pub-id-type="pmid">16225695</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Preethi</surname><given-names>KC</given-names></name><name><surname>Kuttan</surname><given-names>R</given-names></name><article-title>Hepato and reno protective action of <italic>Calendula officinalis</italic> L. flower extract</article-title><source>Indian J. Exp. Biol</source><year>2009</year><volume>47</volume><fpage>163</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">19405380</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Khan</surname><given-names>RA</given-names></name><name><surname>Khan</surname><given-names>MR</given-names></name><name><surname>Sahreen</surname><given-names>S</given-names></name><article-title>Evaluation of <italic>Launaea procumbens</italic> use in renal disorders: A rat model</article-title><source>J</source><year>2010</year><volume>128</volume><fpage>452</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2010.01.026</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Murugesan</surname><given-names>GS</given-names></name><name><surname>Sathishkumar</surname><given-names>M</given-names></name><name><surname>Jayabalan</surname><given-names>R</given-names></name><name><surname>Binupriya</surname><given-names>AR</given-names></name><name><surname>Swaminathan</surname><given-names>K</given-names></name><name><surname>Yun</surname><given-names>SEZ</given-names></name><article-title>Hepatoprotective and curative properties of Kombucha tea against carbon tetrachloride-induced toxicity</article-title><source>J Microbiol Biotechnol</source><year>2009</year><volume>19</volume><fpage>397</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.4014/jmb.0806.374</pub-id><pub-id pub-id-type="pmid">19420997</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Werner</surname><given-names>M</given-names></name><name><surname>Costa</surname><given-names>MJ</given-names></name><name><surname>Mitchell</surname><given-names>LG</given-names></name><name><surname>Nayar</surname><given-names>R</given-names></name><article-title>Nephrotoxicity of xenobiotics</article-title><source>Review Clin</source><year>1995</year><volume>237</volume><fpage>107</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1016/0009-8981(95)06068-O</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Ogeturk</surname><given-names>M</given-names></name><name><surname>Kus</surname><given-names>I</given-names></name><name><surname>Colakoglu</surname><given-names>N</given-names></name><name><surname>Zararsiz</surname><given-names>I</given-names></name><name><surname>Ilhan</surname><given-names>N</given-names></name><name><surname>Sarsilmaz</surname><given-names>M</given-names></name><article-title>Caffeic acid phenethyl ester protects kidneys against carbon tetrachloride toxicity in ratsJ</article-title><source>Ethnopharmacol</source><year>2005</year><volume>97</volume><fpage>273</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2004.11.019</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Jaramillo-Juarez</surname><given-names>F</given-names></name><name><surname>Rodriguez-Vazquez</surname><given-names>ML</given-names></name><name><surname>Rincon-Sanchez</surname><given-names>AR</given-names></name><name><surname>Consolacion</surname><given-names>M</given-names></name><name><surname>Martinez</surname><given-names>GG</given-names></name><name><surname>Ortiz</surname><given-names>J</given-names></name><name><surname>Reyes</surname><given-names>JL</given-names></name><article-title>Caffeic acid phenethyl ester against carbon tetrachloride toxicity in rats</article-title><source>Ann Hepatol</source><year>2008</year><volume>7</volume><fpage>331</fpage><lpage>338</lpage><pub-id pub-id-type="pmid">19034232</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Weber</surname><given-names>LW</given-names></name><name><surname>Boll</surname><given-names>M</given-names></name><name><surname>Stampfl</surname><given-names>M</given-names></name><article-title>Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model</article-title><source>Crit. Revw. Toxicol</source><year>2003</year><volume>33</volume><fpage>105</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1080/713611034</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Miyazaki</surname><given-names>T</given-names></name><name><surname>Bouscarel</surname><given-names>B</given-names></name><name><surname>Ikegami</surname><given-names>T</given-names></name><name><surname>Honda</surname><given-names>A</given-names></name><name><surname>Matsuzaki</surname><given-names>Y</given-names></name><article-title>The protective effect of taurine against hepatic damage in a model of liver disease and hepatic stellate cells</article-title><source>Adv</source><year>2009</year><volume>643</volume><fpage>293</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1007/978-0-387-75681-3_30</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>Khan</surname><given-names>MR</given-names></name><name><surname>Rizvi</surname><given-names>W</given-names></name><name><surname>Khan</surname><given-names>GN</given-names></name><name><surname>Khan</surname><given-names>RA</given-names></name><name><surname>Shaheen</surname><given-names>S</given-names></name><article-title>Carbon tetrachloride induced nephrotoxicity in rat: Protective role of <italic>Digera muricata</italic></article-title><source>J Ethnopharmacol</source><year>2009</year><volume>122</volume><fpage>91</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2008.12.006</pub-id><pub-id pub-id-type="pmid">19118616</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>Khan</surname><given-names>RA</given-names></name><name><surname>Daud</surname><given-names>A</given-names></name><article-title>Protective effects of <italic>Digera muricata</italic> (L.) Mart. on testis against oxidative stress of carbon tetrachloride in rat</article-title><source>Food Chem. Toxicol</source><year>2009</year><volume>47</volume><fpage>1393</fpage><lpage>1399</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2009.03.020</pub-id><pub-id pub-id-type="pmid">19327381</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Adewole</surname><given-names>SO</given-names></name><name><surname>Salako</surname><given-names>AA</given-names></name><name><surname>Doherty</surname><given-names>OW</given-names></name><name><surname>Naicker</surname><given-names>T</given-names></name><article-title>Effect of melatonin on carbon tetrachloride-induced kidney injury in Wistar rats</article-title><source>African J</source><year>2007</year><volume>10</volume><fpage>153</fpage><lpage>164</lpage></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Jia</surname><given-names>X</given-names></name><name><surname>Han</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><article-title>Effect of tea on preneoplastic lesions and cell cycle regulators in rat liver</article-title><source>Cancer Epidemiol</source><year>2002</year><volume>11</volume><fpage>1663</fpage><lpage>1667</lpage></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Fahmy</surname><given-names>SR</given-names></name><name><surname>Hamdi</surname><given-names>SAH</given-names></name><name><surname>Abdel-Salam</surname><given-names>HA</given-names></name><article-title>Curative effect of dietary freshwater and marine crustacean extracts on carbon tetrachloride-induced nephrotoxicity</article-title><source>Australian J</source><year>2009</year><volume>3</volume><fpage>2118</fpage><lpage>2129</lpage></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>Sai</surname><given-names>K</given-names></name><name><surname>Tyson</surname><given-names>CA</given-names></name><name><surname>Thomas</surname><given-names>DW</given-names></name><name><surname>Dabbs</surname><given-names>JE</given-names></name><name><surname>Hasegawa</surname><given-names>R</given-names></name><name><surname>Kurokawa</surname><given-names>Y</given-names></name><article-title>Oxidative DNA damage induced by potassium bromate in isolated rat renal proximal tubules and renal nuclei</article-title><source>Cancer Lett</source><year>1994</year><volume>87</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/0304-3835(94)90402-2</pub-id><pub-id pub-id-type="pmid">7954362</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Khan</surname><given-names>RA</given-names></name><article-title>Protective effect of <italic>Launaea procumbens</italic> (L.) on lungs against CCl<sub>4</sub> induced toxicity in rat</article-title><source>BMC Compl Alter Med</source><year>2012</year><volume>12</volume><fpage>133</fpage><pub-id pub-id-type="doi">10.1186/1472-6882-12-133</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Potter</surname><given-names>JD</given-names></name><article-title>Cancer prevention: epidemiology and experiment</article-title><source>Cancer Lett</source><year>1997</year><volume>114</volume><fpage>7</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/S0304-3835(97)04615-6</pub-id><pub-id pub-id-type="pmid">9103244</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="book"><name><surname>Rice-Evans</surname><given-names>C</given-names></name><name><surname>Packer</surname><given-names>L</given-names></name><source>Flavonoids in health and diseases</source><year>1998</year><publisher-name>New York: Marcel Decker Inc.</publisher-name><fpage>483</fpage><lpage>522</lpage></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="book"><name><surname>Hollman</surname><given-names>PC</given-names></name><name><surname>Katan</surname><given-names>MB</given-names></name><person-group person-group-type="editor">Rice-Evans C, Packer L</person-group><article-title>Absorption, metabolism and bioavailability of flavonoids</article-title><source>Flavonoids in Health and Disease</source><year>1998</year><publisher-name>New York: Marcel Decker</publisher-name><fpage>483</fpage><lpage>522</lpage></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Ishimitsu</surname><given-names>S</given-names></name><name><surname>Tonogai</surname><given-names>Y</given-names></name><article-title>Effects of quercetin and rutin on serum and hepatic lipid concentrations, fecal steroid excretion and serum antioxidant properties</article-title><source>J</source><year>2000</year><volume>46</volume><fpage>229</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1248/jhs.46.229</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Deschner</surname><given-names>EE</given-names></name><name><surname>Ruperto</surname><given-names>J</given-names></name><name><surname>Wong</surname><given-names>G</given-names></name><name><surname>Newmark</surname><given-names>HL</given-names></name><article-title>Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia</article-title><source>Carcinogenesis</source><year>1991</year><volume>12</volume><fpage>1193</fpage><lpage>1196</lpage><pub-id pub-id-type="doi">10.1093/carcin/12.7.1193</pub-id><pub-id pub-id-type="pmid">2070483</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Aleksandrov</surname><given-names>PN</given-names></name><name><surname>Speranskaia</surname><given-names>TV</given-names></name><name><surname>Bobkov Iu</surname><given-names>G</given-names></name><name><surname>Zagorevskii</surname><given-names>VA</given-names></name><name><surname>Zykov</surname><given-names>DA</given-names></name><article-title>Effect of rutin and esculamine on models of aseptic inflammation</article-title><source>Farmakol. Toksikol</source><year>1986</year><volume>49</volume><fpage>84</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">3948995</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Bear</surname><given-names>WL</given-names></name><name><surname>Teel</surname><given-names>RW</given-names></name><article-title>Effects of citrus flavonoids on the mutagenicity of heterocyclic amines and on cytochrome P450 1A2 activity</article-title><source>Anticancer Res</source><year>2000</year><volume>20</volume><fpage>3609</fpage><lpage>3614</lpage><pub-id pub-id-type="pmid">11131669</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Pozin</surname><given-names>VM</given-names></name><name><surname>Skuratovskaia</surname><given-names>SG</given-names></name><name><surname>Pocheptsova</surname><given-names>GA</given-names></name><article-title>Changes in the vascular wall and ischemic damages to the myocardium in reversible episodes of heart muscle ischemia</article-title><source>Fiziologic</source><year>1996</year><volume>42</volume><fpage>10</fpage><lpage>16</lpage></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Gong</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Mohammed</surname><given-names>U</given-names></name><article-title>Naturally occurring polyphenolic antioxidants modulate IgE-mediated mast cell activation</article-title><source>Immunology</source><year>2000</year><volume>100</volume><fpage>471</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2567.2000.00045.x</pub-id><pub-id pub-id-type="pmid">10929074</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>Chance</surname><given-names>B</given-names></name><name><surname>Maehly</surname><given-names>AC</given-names></name><article-title>Assay of catalase and peroxidases</article-title><source>Methods Enzymol</source><year>1955</year><volume>11</volume><fpage>764</fpage><lpage>775</lpage></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name><surname>Kakkar</surname><given-names>P</given-names></name><name><surname>Das</surname><given-names>B</given-names></name><name><surname>Viswanathan</surname><given-names>PN</given-names></name><article-title>A modified spectrophotometric assay of superoxide dismutase</article-title><source>Indian J</source><year>1984</year><volume>21</volume><fpage>130</fpage><lpage>132</lpage></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>Habig</surname><given-names>WH</given-names></name><name><surname>Pabst</surname><given-names>MJ</given-names></name><name><surname>Jakoby</surname><given-names>WB</given-names></name><article-title>Glutathione-S-transferases: the first enzymatic step in mercapturic acid formation</article-title><source>J Biol Chem</source><year>1974</year><volume>249</volume><fpage>7130</fpage><lpage>7139</lpage><pub-id pub-id-type="pmid">4436300</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Carlberg</surname><given-names>I</given-names></name><name><surname>Mannervik</surname><given-names>EB</given-names></name><article-title>Glutathione level in rat brain</article-title><source>J Biol Chem</source><year>1975</year><volume>250</volume><fpage>4475</fpage><lpage>4480</lpage></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Mohandas</surname><given-names>J</given-names></name><name><surname>Marshal</surname><given-names>JJ</given-names></name><name><surname>Duggin</surname><given-names>GG</given-names></name><name><surname>Horvath</surname><given-names>JS</given-names></name><name><surname>Tiller</surname><given-names>DJ</given-names></name><article-title>Differential distribution of glutathione and glutathione-related enzymes in rabbit kidney. Possible implications in analgesic nephropathy</article-title><source>Biochem Pharmacol</source><year>1984</year><volume>33</volume><fpage>1801</fpage><lpage>1807</lpage><pub-id pub-id-type="doi">10.1016/0006-2952(84)90353-8</pub-id><pub-id pub-id-type="pmid">6145422</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><name><surname>Jollow</surname><given-names>DJ</given-names></name><name><surname>Mitchell</surname><given-names>JR</given-names></name><name><surname>Zampaglione</surname><given-names>N</given-names></name><name><surname>Gillete</surname><given-names>JR</given-names></name><article-title>Bromobenzene induced liver necrosis. Protective role of glutathione and evidence for 3, 4-bromobenzene oxide as a hepatotoxic metabolite</article-title><source>Pharmacol</source><year>1974</year><volume>11</volume><fpage>151</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1159/000136485</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><name><surname>Iqbal</surname><given-names>M</given-names></name><name><surname>Sharma</surname><given-names>SD</given-names></name><name><surname>Zadeh</surname><given-names>HR</given-names></name><name><surname>Hasan</surname><given-names>N</given-names></name><name><surname>Abdulla</surname><given-names>M</given-names></name><name><surname>Athar</surname><given-names>M</given-names></name><article-title>Glutathione metabolizing enzymes and oxidative stress in ferric nitrilotriacetate (Fe-NTA) mediated hepatic injury</article-title><source>Redox Report</source><year>1996</year><volume>2</volume><fpage>385</fpage><lpage>391</lpage></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>B</given-names></name><name><surname>Ootani</surname><given-names>A</given-names></name><name><surname>Iwakiri</surname><given-names>R</given-names></name><name><surname>Sakata</surname><given-names>Y</given-names></name><name><surname>Fujise</surname><given-names>T</given-names></name><name><surname>Amemori</surname><given-names>S</given-names></name><name><surname>Yokoyama</surname><given-names>F</given-names></name><name><surname>Tsunada</surname><given-names>S</given-names></name><name><surname>Fujimoto</surname><given-names>K</given-names></name><article-title>T cell deficiency leads to liver carcinogenesis in Azoxymethane-treated rats</article-title><source>Exp</source><year>2005</year><volume>231</volume><fpage>91</fpage><lpage>98</lpage></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><name><surname>Trere</surname><given-names>D</given-names></name><name><surname>Zilbering</surname><given-names>A</given-names></name><name><surname>Dittus</surname><given-names>D</given-names></name><name><surname>Kim</surname><given-names>P</given-names></name><name><surname>Ginsberg</surname><given-names>PC</given-names></name><name><surname>Daskal</surname><given-names>I</given-names></name><article-title>AgNOR quantity in needle biopsy specimens of prostatic adenocarcinomas: correlation with proliferation state, Gleason score, clinical stage, and DNA content</article-title><source>Clin Mol Pathol</source><year>1996</year><volume>49</volume><fpage>209</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1136/mp.49.4.M209</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><name><surname>Aruoma</surname><given-names>OI</given-names></name><article-title>Methodological consideration for characterizing potential antioxidant action of bioactive components in plants foods</article-title><source>Mutat Res</source><year>2003</year><volume>523-524</volume><fpage>9</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">12628499</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><name><surname>Sun</surname><given-names>Y</given-names></name><article-title>Free radicals, antioxidant enzymes and carcinogenesis</article-title><source>Free Radic Biol Med</source><year>1990</year><volume>8</volume><fpage>583</fpage><lpage>599</lpage><pub-id pub-id-type="doi">10.1016/0891-5849(90)90156-D</pub-id><pub-id pub-id-type="pmid">2193855</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><name><surname>Aleynick</surname><given-names>SI</given-names></name><name><surname>Leo</surname><given-names>MA</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Aleynick</surname><given-names>MK</given-names></name><article-title>Polyenoyl phasphatidylcholine prevents CCl<sub>4</sub> induced lipid peroxidation while C.S. it attenuates liver fibrosis</article-title><source>J Hepatol</source><year>1997</year><volume>27</volume><fpage>554</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1016/S0168-8278(97)80361-3</pub-id><pub-id pub-id-type="pmid">9314134</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><name><surname>Cheng</surname><given-names>HL</given-names></name><name><surname>Hu</surname><given-names>YY</given-names></name><name><surname>Wang</surname><given-names>RP</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Zhu</surname><given-names>DY</given-names></name><article-title>Protective actions of salvianolic acid on hepatocyte injured by peroxidation in vitro</article-title><source>World J Gastroenterol</source><year>2000</year><volume>6</volume><fpage>402</fpage><lpage>404</lpage><pub-id pub-id-type="pmid">11819609</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><name><surname>Xiao-hui</surname><given-names>H</given-names></name><name><surname>Liang-qi</surname><given-names>C</given-names></name><name><surname>Xi-ling</surname><given-names>C</given-names></name><name><surname>Kai</surname><given-names>S</given-names></name><name><surname>Yun-jian</surname><given-names>L</given-names></name><name><surname>Long-juan</surname><given-names>Z</given-names></name><article-title>Polyphenol epigallocatechin-3-gallate inhibits oxidative damage and preventive effects on carbon tetrachloride&#x02013;induced hepatic fibrosis</article-title><source>Nutr</source><year>2007</year><volume>3</volume><fpage>511</fpage><lpage>515</lpage></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>JR</given-names></name><name><surname>Erdman</surname><given-names>JWJ</given-names></name><name><surname>Zhou</surname><given-names>JR</given-names></name><name><surname>Erdman</surname><given-names>JWJ</given-names></name><article-title>Phytic acid in health and disease</article-title><source>Crit. Rev. Food Sci. Nutr</source><year>1995</year><volume>35</volume><fpage>495</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1080/10408399509527712</pub-id><pub-id pub-id-type="pmid">8777015</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="other"><name><surname>Sreelatha</surname><given-names>S</given-names></name><name><surname>Padma</surname><given-names>PR</given-names></name><name><surname>Umadevi</surname><given-names>M</given-names></name><article-title>Protective effects of <italic>Coriandrum sativume</italic> xtracts on CCl<sub>4</sub>- induced hepatotoxicity in rats.<italic>Food Chem</italic></article-title><source>Toxicol</source><pub-id pub-id-type="doi">10.1016/j.fct.2009.12.022</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><name><surname>Recknagel</surname><given-names>RO</given-names></name><name><surname>Glande</surname><given-names>EAJ</given-names></name><article-title>Carbon tetrachloride hepatotoxicity: an example of lethal cleavage</article-title><source>Critical. Rev. Toxicol</source><year>1973</year><volume>2</volume><fpage>263</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.3109/10408447309082019</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><name><surname>Al-Shabanah</surname><given-names>OA</given-names></name><name><surname>Alam</surname><given-names>K</given-names></name><name><surname>Nagi</surname><given-names>MN</given-names></name><name><surname>Al-Rikabi</surname><given-names>AC</given-names></name><name><surname>Al-Bekairi</surname><given-names>AM</given-names></name><article-title>Protective effect of aminoguanidine, a nitric oxide synthetase inhibiter against CCl<sub>4</sub> induced hepatotoxicity in mice</article-title><source>Life Sci</source><year>2000</year><volume>66</volume><fpage>265</fpage><lpage>270</lpage><pub-id pub-id-type="pmid">10666002</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><name><surname>Janbaz</surname><given-names>KH</given-names></name><name><surname>Gilani</surname><given-names>AH</given-names></name><article-title>Evaluation of protective potential of <italic>Artemisia maritima</italic> extract on acetaminophen and CCl<sub>4</sub> induced liver damage</article-title><source>J Ethnopharmacol</source><year>1955</year><volume>47</volume><fpage>43</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">7564420</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><name><surname>Chandan</surname><given-names>BK</given-names></name><name><surname>Sharma</surname><given-names>AK</given-names></name><name><surname>Anand</surname><given-names>KK</given-names></name><article-title><italic>Boerhaavia diffusa</italic>: a study of its hepatoprotective activity</article-title><source>J Ethnopharmacol</source><year>1991</year><volume>31</volume><fpage>299</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1016/0378-8741(91)90015-6</pub-id><pub-id pub-id-type="pmid">2056758</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><name><surname>Manna</surname><given-names>P</given-names></name><name><surname>Sinha</surname><given-names>M</given-names></name><name><surname>Sil</surname><given-names>PC</given-names></name><article-title>Aqueous extract of <italic>Terminalia arjuna</italic> prevents carbon tetrachloride induced hepatic and renal disorders</article-title><source>BMC Compl</source><year>2007</year><volume>6</volume><fpage>33</fpage><lpage>37</lpage></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><name><surname>Yadav</surname><given-names>P</given-names></name><name><surname>Sarkar</surname><given-names>S</given-names></name><name><surname>Bhatnagar</surname><given-names>D</given-names></name><article-title>Action of <italic>Capparis deciduas</italic> against alloxan-induced oxidative stress and diabetes in rat tissues</article-title><source>Pharmacol Res</source><year>1997</year><volume>36</volume><fpage>221</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1006/phrs.1997.0222</pub-id><pub-id pub-id-type="pmid">9367667</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><name><surname>Gumieniczek</surname><given-names>A</given-names></name><article-title>Effects of repaglinide on oxidative stress in tissues of diabetic rabbits</article-title><source>Diab</source><year>2005</year><volume>68</volume><fpage>89</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/j.diabres.2004.09.018</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><name><surname>Maritim</surname><given-names>AC</given-names></name><name><surname>Sanders</surname><given-names>RA</given-names></name><name><surname>Watkins</surname><given-names>JB</given-names></name><article-title>Effects of &#x003b1;-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats</article-title><source>J Nutr Biochem</source><year>2003</year><volume>14</volume><fpage>288</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1016/S0955-2863(03)00036-6</pub-id><pub-id pub-id-type="pmid">12832033</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><name><surname>Cheeseman</surname><given-names>KH</given-names></name><article-title>Mechanisms and effects of lipid peroxidation</article-title><source>Mol Aspects Med</source><year>1993</year><volume>14</volume><fpage>191</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1016/0098-2997(93)90005-X</pub-id><pub-id pub-id-type="pmid">8264333</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><name><surname>Marnett</surname><given-names>JL</given-names></name><article-title>Oxyridicals and DNA damage</article-title><source>Carcinogenesis</source><year>2000</year><volume>21</volume><fpage>61</fpage><lpage>70</lpage></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><name><surname>Van Gijssel</surname><given-names>HE</given-names></name><name><surname>Maassen</surname><given-names>CB</given-names></name><name><surname>Mulder</surname><given-names>GJ</given-names></name><name><surname>Meerman</surname><given-names>JH</given-names></name><article-title>P53 protein expression by hepatocarcinogens in the rat liver and its potential role in mitoinhibition of normal hepatocytes as a mechanism of hepatic tumor promotion</article-title><source>Carcinogenesis</source><year>1997</year><volume>18</volume><fpage>1027</fpage><lpage>1031</lpage><pub-id pub-id-type="doi">10.1093/carcin/18.5.1027</pub-id><pub-id pub-id-type="pmid">9163691</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><name><surname>Farazi</surname><given-names>PA</given-names></name><name><surname>Zeisberg</surname><given-names>M</given-names></name><name><surname>Glickman</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Kalluri</surname><given-names>R</given-names></name><name><surname>DePinh</surname><given-names>RA</given-names></name><article-title>Chronic bile duct injury associated with fibrotic matrix micro environment provokes cholangiocarcinoma in p53-deficient mice</article-title><source>Nutri</source><year>2006</year><volume>6</volume><fpage>6622</fpage><lpage>66277</lpage></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><name><surname>Kuo</surname><given-names>PL</given-names></name><name><surname>Lin</surname><given-names>C</given-names></name><name><surname>Kuo</surname><given-names>PL</given-names></name><name><surname>Lin</surname><given-names>CC</given-names></name><article-title>Green tea constituent (&#x02212;) - epigallocatechin-3-gallate inhibits Hep G2 cell. Proliferaration and induces apoptosis through p53-dependent and fas-mediated pathways</article-title><source>J Biomed Sci</source><year>2003</year><volume>10</volume><fpage>219</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">12595758</pub-id></mixed-citation></ref></ref-list></back></article>